Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
Nat Commun. 2020 May 15;11(1):2416. doi: 10.1038/s41467-020-16199-4.
Nat Commun. 2020.
PMID: 32415208
Free PMC article.